Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer-A case-control study in a Chinese population

Lung Cancer

Volumn 80, Issue 2, 2013, Pages 131-137

  Myneni, Ajay A ^a   Chang, Shen Chih ^b   Niu, Rungui ^c   Liu, Li ^d   Ochs Balcom, Heather M ^a   Li, Yanli ^a   Zhang, Chao ^e   Zhao, Baoxing ^d   Shi, Jianping ^d   Han, Xiaoyou ^c   Li, Jiawei ^f   Su, Jia ^f   Cai, Lin ^g   Yu, Shunzhang ^f   Zhang, Zuo Feng ^b   Mu, Lina ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHANXI TUMOR HOSPITAL   (China)

^d Taiyuan Center for Disease Control and Prevention   (China)

^e SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^f FUDAN UNIVERSITY   (China)

^g FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Chinese population; CLPTM1L; Lung cancer; SNPs; Susceptibility; TERT

Indexed keywords

CLEFT LIP AND PALATE TRANSMEMBRANE 1 LIKE PROTEIN; MEMBRANE PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINA; CHINESE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDOOR AIR POLLUTION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TELOMERASE;

EID: 84875904958     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.01.021     Document Type: Article

References (31)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
2. Chen W., Zhang S., Zou X. Evaluation on the incidence, mortality and tendency of lung cancer in China. Thoracic Cancer 2010, 1:35-40.
3. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
4. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers - a different disease. Nat Rev Cancer 2007, 7:778-790.
5. Guo P., Huang Z.L., Yu P., Li K. Trends in cancer mortality in China: an update. Ann Oncol 2012.
6. Lam W.K., White N.W., Chan-Yeung M.M. Lung cancer epidemiology and risk factors in Asia and Africa. Int J Tuberc Lung Dis 2004, 8:1045-1057.
7. McKay J.D., Hung R.J., Gaborieau V., Boffetta P., Chabrier A., Byrnes G., et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008, 40:1404-1406.
8. Rafnar T., Sulem P., Stacey S.N., Geller F., Gudmundsson J., Sigurdsson A., et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009, 41:221-227.
9. Wang Y., Broderick P., Matakidou A., Eisen T., Houlston R.S. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis 2010, 31:234-238.
10. Hosmer D.W., Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992, 3:452-456.
11. Rothman K.J., Greenland S. Modern epidemiology 1998, Lippincott Williams & Wilkins, New York. 2nd ed.
12. Andersson T., Alfredsson L., Källberg H., Zdravkovic S., Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005, 20:575-579.
13. Jin G., Xu L., Shu Y., Tian T., Liang J., Xu Y., et al. Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis 2009, 30:987-990.
14. Bae E.Y., Lee S.Y., Kang B.K., Lee E.J., Choi Y.Y., Kang H.G., et al. Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology 2012, 17:699-706.
15. Landi M.T., Chatterjee N., Yu K., Goldin L.R., Goldstein A.M., Rotunno M., et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 2009, 85:679-691.
16. Young N.S. Telomere biology and telomere diseases: implications for practice and research. Hematology Am Soc Hematol Educ Program 2010, 2010:30-35.
17. Wyatt H.D., West S.C., Beattie T.L. InTERTpreting telomerase structure and function. Nucleic Acids Res 2010, 38:5609-5622.
18. Rodier F., Kim S.H., Nijjar T., Yaswen P., Campisi J. Cancer and aging: the importance of telomeres in genome maintenance. Int J Biochem Cell Biol 2005, 37:977-990.
19. McEachern M.J., Krauskopf A., Blackburn E.H. Telomeres and their control. Annu Rev Genet 2000, 34:331-358.
20. Lantuejoul S., Salon C., Soria J.C., Brambilla E. Telomerase expression in lung preneoplasia and neoplasia. Int J Cancer 2007, 120:1835-1841.
21. Fernandez-Garcia I., Ortiz-de-Solorzano C., Montuenga L.M. Telomeres and telomerase in lung cancer. J Thorac Oncol 2008, 3:1085-1088.
22. Blanco D., Vicent S., Fraga M.F., Fernandez-Garcia I., Freire J., Lujambio A., et al. Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway. Neoplasia 2007, 9:840-852.
23. Cha N., Li X.Y., Zhao Y.J., Wang E.H., Wu G.P. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer. Clin Lung Cancer 2012.
24. Truong T., Hung R.J., Amos C.I., Wu X., Bickeboller H., Rosenberger A., et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 2010, 102:959-971.
25. Vaziri H., Dragowska W., Allsopp R.C., Thomas T.E., Harley C.B., Lansdorp P.M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91:9857-9860.
26. Calado R., Young N. Telomeres in disease. F1000 Med Rep 2012, 4:8.
27. Lam W.K. Lung cancer in Asian women - the environment and genes. Respirology 2005, 10:408-417.
28. Yamamoto K., Okamoto A., Isonishi S., Ochiai K., Ohtake Y. A novel gene CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 2001, 280:1148-1154.
29. James M.A., Wen W., Wang Y., Byers L.A., Heymach J.V., Coombes K.R., et al. Functional characterization of CLPTM1L as a Lung cancer risk candidate gene in the 5p15.33 Locus. PLoS ONE 2012, 7:e36116.
30. Zienolddiny S., Skaug V., Landvik N.E., Ryberg D., Phillips D.H., Houlston R., et al. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 2009, 30:1368-1371.
31. Wang Y., Broderick P., Webb E., Wu X., Vijayakrishnan J., Matakidou A., et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008, 40:1407-1409.